Cause of death, by non-communicable diseases, ages 5-14 in Kyrgyzstan
Kyrgyzstan: Cause of death, by non-communicable diseases, ages 5-14 was 36.0% in 2021. ▲ Rising
Cause of death, by non-communicable diseases, ages 5-14 in Kyrgyzstan, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total deaths ages 5-14.
Analysis
The most recent figure for cause of death, by non-communicable diseases, ages 5-14 in Kyrgyzstan is 36.0%, measured in 2021.
The figure is down 0.6% on the previous year and up 12.5% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 5-14 in Kyrgyzstan peaked at 37.8% in 2019 and was at its lowest, 28.5%, in 2000.
Kyrgyzstan ranks 100th of 185 countries on this measure, in the middle of the range.
Cause of death, by non-communicable diseases, ages 5-14 in Kyrgyzstan, year by year
| Year | % of total deaths ages 5-14 | Change |
|---|---|---|
| 2000 | 28.5% | — |
| 2010 | 32.0% | +12.3% |
| 2015 | 37.4% | +16.7% |
| 2019 | 37.8% | +1.2% |
| 2020 | 36.2% | -4.2% |
| 2021 | 36.0% | -0.6% |
Kyrgyzstan compared with similar countries
- Kyrgyzstan's 36.0% is above the median for lower middle income countries, which is 25.3%, 1.4× the median. (47 countries reporting)
- Kyrgyzstan's 36.0% is below the median for Europe & Central Asia, which is 58.0%, 62% of the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 28.5% | 28.5% | 28.5% | 1 |
| 2010s | 35.7% | 32.0% | 37.8% | 3 |
| 2020s | 36.1% | 36.0% | 36.2% | 2 |
Countries ranked near Kyrgyzstan
More health data for Kyrgyzstan
- Un projection of annual infant deaths, annual growth rate -1.77 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6971 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 938.9 deaths per 1,000 people (2090)
- Number of infants who die before age 1 278 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2023)
- Population ages 00-04, female, annual growth rate -1.95 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0501 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.01 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 5-14 in Kyrgyzstan?
- Cause of death, by non-communicable diseases, ages 5-14 in Kyrgyzstan was 36.0% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 5-14 recorded in Kyrgyzstan?
- The highest recorded value was 37.8% in 2019.
- What is the lowest cause of death, by non-communicable diseases, ages 5-14 recorded in Kyrgyzstan?
- The lowest recorded value was 28.5% in 2000.
- How does Kyrgyzstan rank for cause of death, by non-communicable diseases, ages 5-14?
- Kyrgyzstan ranks 100th out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 5-14 rising or falling in Kyrgyzstan?
- Over the last ten years it is up 12.5%. The long-run trend across the full record is rising.
- Where does this Kyrgyzstan data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 5-14 (% of total deaths ages 5-14). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of deaths ages 5-14 due to non-communicable diseases divided by number of all deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.